SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors aggressively rotate into semiconductor stocks following strong sector-wide sentiment, with the community actively debating whether the current momentum is a sustainable long-term re-rating or an overextended bubble primed for a pullback ahead of earnings. While many investors are expressing high conviction in the CPU-to-GPU shift and the company's long-term growth narrative, bears are citing extreme technical indicators and elevated valuations as catalysts for potential near-term volatility.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera Inc. is trending as investors aggressively speculate on a potential major commercial licensing deal following an expanded collaboration with Synopsys and ongoing work with key equipment partners in the semiconductor space. The community is sharply divided between retail bulls anticipating a breakout on high volume and skeptics who highlight the company's long history of pre-revenue status and capital-raising activities.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Dominos Pizza is currently drawing significant attention from investors as it navigates an upcoming earnings release, with many in the community debating the company's valuation and the effectiveness of its latest strategic initiatives. While some market participants see an attractive entry point due to the stock's recent price consolidation, others are closely monitoring franchise-level challenges and broader consumer spending trends that could influence its near-term performance.

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining traction as a high-volatility meme coin, with the community actively rallying around the developer's commitment to avoiding rug pulls through transparent token burns and manual airdrops. Investors are currently hyper-focused on the project's growth potential and upcoming charting developments, urging others to buy and hold as they aim to hit key market cap milestones.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is facing intense scrutiny as investors debate whether recent price weakness represents a long-term fundamental breakdown or a prime buying opportunity driven by mispriced iron and steel demand. The community is heavily focused on potential asset sales, ongoing speculation regarding a POSCO partnership, and the company's ability to navigate debt amidst shifting domestic infrastructure and industrial policies.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is experiencing a significant surge driven by the FDA’s decision to lift clinical holds on key gene-editing programs, which has triggered heavy buying pressure against a massive short interest. Investors are currently focused on the upcoming Phase 3 readout for HAE, viewing the company’s in vivo CRISPR technology as a potential game-changer that could redefine the biotech sector.

RE/MAX Holdings, Inc. engages in the provision of real estate franchise services through its subsidiaries. It operates through the following segments: Real Estate, Mortgage and Marketing Funds. The Real Estate segment consists of the company’s owned and independent global franchising operations under the RE/MAX brand name and technology and data subscription for Gadberry and the First app. The Mortgage segment consists of the firm's mortgage brokerage franchising operations under the Motto Mortgage brand name and mortgage loan processing services and licensed software under the wemlo brand. The Marketing Funds segment is involved in marketing campaigns designed to build and maintain brand awareness and the development and operation of agent marketing technology. The company was founded by David L. Liniger and Gail A. Liniger in 1973 and is headquartered in Denver, CO.

RE/MAX Holdings Inc - Ordinary Shares - Class A

RE/MAX Holdings is seeing increased investor attention as the market evaluates its position within a cooling housing environment and potential long-term consolidation of the brokerage sector. The community is actively debating the stock's valuation, insider activity, and how the company's franchise model will adapt to shifting commission structures and ongoing interest rate pressures.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing intense community debate as investors weigh the potential of the upcoming Goliath mainnet launch against persistent skepticism regarding project transparency and historical price volatility. While some participants are actively accumulating and staking in anticipation of institutional adoption, others express frustration over stagnant price action and are warning of potential downside risks.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy's Nasdaq debut is driving intense market interest as investors flock to the Amazon-backed nuclear firm, which is positioned as a key player in solving the power demands of AI data centers. The community is actively debating the company's valuation and project pipeline compared to peers while closely watching for price momentum following its significantly oversubscribed IPO.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors react to a new $20 billion stock buyback and a dividend increase, which are helping to stabilize sentiment following recent concerns over handset demand and memory supply chain constraints. The community remains focused on the company's pivot toward edge AI, automotive partnerships, and data center opportunities, with many discussing whether the current price represents a long-term value entry or a cautionary signal for the broader semiconductor sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the appointment of Christy Shafer as Chief Commercial Officer and the appointment of Christine Mikail, J.D., to...

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the...

Neurogene (NASDAQ:NGNE) Given New $180.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group reduced their price target on shares of Neurogene from $200.00 to $180.00 and set a "buy" rating on the stock in a research report on Monday...

Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the firm...

Equities Analysts Set Expectations for Neurogene Q1 Earnings

Neurogene Inc. (NASDAQ:NGNE - Free Report) - Analysts at HC Wainwright raised their Q1 2026 earnings estimates for Neurogene in a report released on Thursday, March 26th. HC Wainwright analyst M...

Brokers Issue Forecasts for Neurogene FY2027 Earnings

Neurogene Inc. (NASDAQ:NGNE - Free Report) - Equities researchers at HC Wainwright issued their FY2027 earnings per share (EPS) estimates for shares of Neurogene in a report issued on Thursday, March 26th. HC Wainwright analyst M. Kapoor expects that the company will post earnings per share of ($4.9...

Q1 Earnings Estimate for Neurogene Issued By Lifesci Capital

Neurogene Inc. (NASDAQ:NGNE - Free Report) - Investment analysts at Lifesci Capital lowered their Q1 2026 earnings per share estimates for Neurogene in a note issued to investors on Tuesday, March...

Neurogene (NASDAQ:NGNE) Announces Quarterly Earnings Results, Beats Expectations By $0.08 EPS

Neurogene (NASDAQ:NGNE - Get Free Report) issued its earnings results on Tuesday. The company reported ($1.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of...

Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced full year...

Neurogene CEO Details NGN-401 Rett Trial, FDA Alignment, and Key 2026 Catalysts at Conference

Neurogene (NASDAQ:NGNE) CEO and founder Rachel McMinn outlined the company's progress toward a potential commercial launch for its lead gene therapy candidate, NGN-401, during a fireside chat focused on Rett syndrome, regulatory alignment, trial design, and upcoming catalysts.

Company focus and lea...

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

Current Price	$27.03
Prev Close	$26.95
Open	$26.81
Dividend Yield	0.00%
50-Day Moving Average	$21.49
Beta	1.58
Avg. Volume	179,008.34
PE Ratio	-5.74

52-Week High	$37.27
52-Week Low	$11.77
Market Capitalization	$422.09M
EPS (Annual)	-$4.24
Price to Book	1.58
Revenue Per Employee	$0.00

NGNE
Neurogene Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NGNE News

NGNENeurogene Inc